Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer
Recruiting now
Conditions studied: Metastatic Castration Resistant Prostate Cancer
In brief
This is a local prospective, multicenter, long-term, non-interventional study using primary data collection to describe the routine clinical practice of patients with mCRPC treated with lutetium (177Lu) vipivotide tetraxetan. The observation period will be from date of start of treatment up to a maximum of 18 months after end of treatment.
Key facts
- Study ID
- NCT07093801
- Run by
- Novartis Pharmaceuticals
- People needed
- 300
- Starts
- 2025-07-30
- Expected to finish
- 2029-03-30
- Last updated by the study team
- 2026-05-15
Who can join
Age: 18 and older, up to 99. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Alessandria, AL, Italy (enrolling)
- Novartis Investigative Site — Asti, AT, Italy (enrolling)
- Novartis Investigative Site — Bergamo, BG, Italy (enrolling)
- Novartis Investigative Site — Brescia, BS, Italy (enrolling)
- Novartis Investigative Site — Catania, CT, Italy (enrolling)
- Novartis Investigative Site — Meldola, FC, Italy (enrolling)
- Novartis Investigative Site — Cona, FE, Italy (enrolling)
- Novartis Investigative Site — Foggia, FG, Italy (enrolling)
- Novartis Investigative Site — Florence, FI, Italy (enrolling)
- Novartis Investigative Site — Genova, GE, Italy (enrolling)
- Novartis Investigative Site — Genova, GE, Italy (enrolling)
- Novartis Investigative Site — Latina, LT, Italy (enrolling)
- Novartis Investigative Site — Province of Macerata, MC, Italy (enrolling)
- Novartis Investigative Site — Milan, MI, Italy (enrolling)
- Novartis Investigative Site — Milan, MI, Italy (enrolling)
- Novartis Investigative Site — Rozzano, MI, Italy (enrolling)
- Novartis Investigative Site — Palermo, PA, Italy (enrolling)
- Novartis Investigative Site — Padova, PD, Italy (enrolling)
- Novartis Investigative Site — Perugia, PG, Italy (enrolling)
- Novartis Investigative Site — Pisa, PI, Italy (enrolling)
- Novartis Investigative Site — Aviano, PN, Italy (enrolling)
- Novartis Investigative Site — Rionero in Vulture, PZ, Italy (enrolling)
- Novartis Investigative Site — Reggio Emilia, RE, Italy (enrolling)
- Novartis Investigative Site — Roma, RM, Italy (enrolling)
- Novartis Investigative Site — Roma, RM, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.